Status:
COMPLETED
Study to Reduce Intravenous Exposures (STRIVE)
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Hepatitis C
HIV Infections
Eligibility:
All Genders
18-35 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to determine whether a six-session, small group behavioral intervention based on "peer-volunteer activism" is effective in (1) decreasing distributive sharing of syringes ...
Detailed Description
The purpose of this study is to determine the efficacy of a peer-volunteer intervention to reduce high-risk transmission behaviors among hepatitis C virus (HCV)-infected young adult injection drug use...
Eligibility Criteria
Inclusion
- HCV antibody positive
- age between 18 and 35 years old;
- reported injection drug use in the past 6 months
- willing to provide a blood sample for liver function testing
Exclusion
- HIV antibody positive
- planned on moving from city within the next 12 months;
- unable to comprehend English well enough to complete English-only assessments and group sessions
Key Trial Info
Start Date :
June 1 2002
Trial Type :
INTERVENTIONAL
End Date :
February 1 2005
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00391482
Start Date
June 1 2002
End Date
February 1 2005
Last Update
January 11 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University, Bloomberg School of Public Health
Baltimore, Maryland, United States, 21205
2
New York Academy of Medicine, Center for Urban Epidemiologic Studies
New York, New York, United States, 10029
3
Public Health Seattle & King County
Seattle, Washington, United States, 98104